Novak-Hofer I - Search Results

1

Evaluation of radioiodinated and radiocopper labeled monovalent fragments of monoclonal antibody chCE7 for targeting of neuroblastoma.

Carrel F, Amstutz H, Novak-Hofer I, Schubiger PA. Carrel F, et al. Nucl Med Biol. 1997 Aug;24(6):539-46. doi: 10.1016/s0969-8051(97)00034-6. Nucl Med Biol. 1997. PMID: 9316082

2

Copper-67 as a therapeutic nuclide for radioimmunotherapy.

Novak-Hofer I, Schubiger PA. Novak-Hofer I, et al. Eur J Nucl Med Mol Imaging. 2002 Jun;29(6):821-30. doi: 10.1007/s00259-001-0724-y. Epub 2002 Feb 2. Eur J Nucl Med Mol Imaging. 2002. PMID: 12029558 Review.

3

Targeting of renal carcinoma with 67/64Cu-labeled anti-L1-CAM antibody chCE7: selection of copper ligands and PET imaging.

Zimmermann K, Grünberg J, Honer M, Ametamey S, Schubiger PA, Novak-Hofer I. Zimmermann K, et al. Nucl Med Biol. 2003 May;30(4):417-27. doi: 10.1016/s0969-8051(03)00019-2. Nucl Med Biol. 2003. PMID: 12767399

4

In vivo evaluation of 177Lu- and 67/64Cu-labeled recombinant fragments of antibody chCE7 for radioimmunotherapy and PET imaging of L1-CAM-positive tumors.

Grünberg J, Novak-Hofer I, Honer M, Zimmermann K, Knogler K, Bläuenstein P, Ametamey S, Maecke HR, Schubiger PA. Grünberg J, et al. Among authors: novak hofer i. Clin Cancer Res. 2005 Jul 15;11(14):5112-20. doi: 10.1158/1078-0432.CCR-05-0227. Clin Cancer Res. 2005. PMID: 16033825

5

Evaluation of 177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo properties.

Knogler K, Grünberg J, Novak-Hofer I, Zimmermann K, Schubiger PA. Knogler K, et al. Among authors: novak hofer i. Nucl Med Biol. 2006 Oct;33(7):883-9. doi: 10.1016/j.nucmedbio.2006.08.001. Nucl Med Biol. 2006. PMID: 17045168

6

Radioimmunolocalization of neuroblastoma xenografts with chimeric antibody chCE7.

Novak-Hofer I, Amstutz HP, Haldemann A, Blaser K, Morgenthaler JJ, Bläuenstein P, Schubiger PA. Novak-Hofer I, et al. J Nucl Med. 1992 Feb;33(2):231-6. J Nucl Med. 1992. PMID: 1732444 Free article.

7

Assessment of the binding properties of Granuloszint.

Schubiger PA, Hasler PH, Novak-Hofer I, Bläuenstein P. Schubiger PA, et al. Eur J Nucl Med. 1989;15(9):605-8. doi: 10.1007/BF00256938. Eur J Nucl Med. 1989. PMID: 2598956

8

Cellular processing of copper-67-labeled monoclonal antibody chCE7 by human neuroblastoma cells.

Novak-Hofer I, Amstutz HP, Mäcke HR, Schwarzbach R, Zimmermann K, Morgenthaler JJ, Schubiger PA. Novak-Hofer I, et al. Cancer Res. 1995 Jan 1;55(1):46-50. Cancer Res. 1995. PMID: 7805039

9

Internalization and degradation of monoclonal antibody chCE7 by human neuroblastoma cells.

Novak-Hofer I, Amstutz HP, Morgenthaler JJ, Schubiger PA. Novak-Hofer I, et al. Int J Cancer. 1994 May 1;57(3):427-32. doi: 10.1002/ijc.2910570322. Int J Cancer. 1994. PMID: 8169006

10

Preclinical evaluation of 67Cu-labeled intact and fragmented anti-colon carcinoma monoclonal antibody MAb35.

Smith A, Alberto R, Blaeuenstein P, Novak-Hofer I, Maecke HR, Schubiger PA. Smith A, et al. Cancer Res. 1993 Dec 1;53(23):5727-33. Cancer Res. 1993. PMID: 8242629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters